Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Soft Tissue Sarcoma — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category
Malignant Neoplasm
Sarcoma
Soft Tissue Sarcoma

Subtype

Soft Tissue Sarcoma

CI-CAN-00001533Explore in graph →

338 active trials9 approved drugs37 evidence items

NCIt: C9306

Overview
Statistics
Survival
Genomics2
Variants & evidence37
Drugs3
Trials1383
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

1,383 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 338
Recruiting: 188
Ph III recruiting: 14
Growth YoY: −16.5%
Industry share: 14%
Top sponsor: National Cancer Institute (NCI)
Termination share: 32.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (195)

StatusAll Active (any)Completed 602 Recruiting 228 Unknown 156 Terminated 151 Active Not Recruiting 102 Not Yet Recruiting 68 Withdrawn 57 No Longer Available 5 Enrolling By Invitation 5 Suspended 4 Available 4 Approved For Marketing 1

PhaseAll Early Phase 1 36 N/A 235 Phase 1 330 Phase 2 547 Phase 3 114 Phase 4 33

No study matches these filters